BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo J, Guo M, Zheng J. Inhibition of Bone Morphogenetic Protein 2 Suppresses the Stemness Maintenance of Cancer Stem Cells in Hepatocellular Carcinoma via the MAPK/ERK Pathway. Cancer Manag Res 2021;13:773-85. [PMID: 33536785 DOI: 10.2147/CMAR.S281969] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Gu H, Yan C, Wan H, Wu L, Liu J, Zhu Z, Gao D. Mesenchymal stem cell-derived exosomes block malignant behaviors of hepatocellular carcinoma stem cells through a lncRNA C5orf66-AS1/microRNA-127-3p/DUSP1/ERK axis. Hum Cell 2021;34:1812-29. [PMID: 34431063 DOI: 10.1007/s13577-021-00599-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ehata S, Miyazono K. Bone Morphogenetic Protein Signaling in Cancer; Some Topics in the Recent 10 Years. Front Cell Dev Biol 2022;10:883523. [DOI: 10.3389/fcell.2022.883523] [Reference Citation Analysis]
3 Guyot B, Lefort S, Voeltzel T, Pécheur EI, Maguer-Satta V. Altered BMP2/4 Signaling in Stem Cells and Their Niche: Different Cancers but Similar Mechanisms, the Example of Myeloid Leukemia and Breast Cancer. Front Cell Dev Biol 2021;9:787989. [PMID: 35047500 DOI: 10.3389/fcell.2021.787989] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]